Combination of 16s rrna variable regions provides a detailed analysis of bacterial community dynamics in the lungs of cystic fibrosis patients

Human Genomics

Volumn 4, Issue 3, 2010, Pages 147-169

  Doud, Melissa S ^a   Light, Michael ^b   Gonzalez, Gisela ^a   Narasimhan, Giri ^a   Mathee, Kalai ^c  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

16S rRNA; AmpliQu ; Cystic fibrosis; Cystic fibrosis microbiome; LH PCR; Metagenome; V1; V1_V2

Indexed keywords

RNA 16S;

ARTICLE; BACTERIUM; CYSTIC FIBROSIS; GENETICS; HUMAN; LUNG; METABOLISM; MICROBIOLOGY; PATHOGENICITY; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA;

BACTERIA; CYSTIC FIBROSIS; HUMANS; LUNG; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; RNA, RIBOSOMAL, 16S;

EID: 85027950847     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-4-3-147     Document Type: Article

References (50)

1. Cystic Fibrosis Foundation. (2008), ‘Patient Registry. Annual Data Report 2008’, Available at: www.cff.org/LivingWithCF/QualityImprove ment/PatientRegistryReport/ [last accessed 1st March, 2010].
2. Riordan, J.R., Rommens, J.M., Kerem, B., Alon, N. et al. (1989), ‘Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA’, Science Vol. 245, pp. 1066–1073.
3. Wainwright, B.J., Scambler, P.J., Schmidtke, J., Watson, E.A. et al. (1985), ‘Localization of cystic fibrosis locus to human chromosome 7cen-q22’, Nature Vol. 318, pp. 384–385.
4. Kunzelmann, K. (1999), ‘The cystic fibrosis transmembrane conductance regulator and its function in epithelial transport’, Rev. Physiol. Biochem. Pharmacol. Vol. 137, pp. 1–70.
5. Lyczak, J.B., Cannon, C.L. and Pier, G.B. (2002), ‘Lung infections associated with cystic fibrosis’, Clin. Microbiol. Rev. Vol. 15, pp. 194–222.
6. Hull, J. (2003), ‘Basic science of cystic fibrosis’, Curr. Paediatr. Vol. 13, pp. 253–258.
7. Mathee, K., Ciofu, O., Sternberg, C., Lindum, P.W. et al. (1999), ‘Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: A mechanism for virulence activation in the cystic fibrosis lung’, Microbiology Vol. 145, pp. 1349–1357.
8. Ward, D., Weller, R. and Bateson, M. (1990), ‘16S rRNA sequences reveal numerous uncultured microorganisms in a natural community’, Nature Vol. 345, pp. 63–65.
9. Ward, D.M., Weller, R. and Bateson, M.M. (1990), ‘16S rRNA sequences reveal uncultured inhabitants of a well-studied thermal com-munity’, FEMS Microbiol. Rev. Vol. 6, pp. 105–115.
10. Belkum, A., Renders, N.H.M., Smith, S., Overbeek, S.E. et al. (2000), ‘Comparisons of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients’, FEMS Immunol. Med. Microbiol. Vol. 27, pp. 51–57.
11. Bittar, F., Richet, H., Dubus, J.C., Reynaud-Gaubert, M. et al. (2008), ‘Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients’, PLoS ONE Vol. 3, p. e2908.
12. Burns, J.L., Emerson, J., Stapp, J.R., Yim, D.L. et al. (1998), ‘Microbiology of sputum from patients at cystic fibrosis centers in the United States’, Clin. Infect. Dis. Vol. 27, pp. 158–163.
13. Coenye, T., Liu, L., Vandamme, P. and LiPuma, J.J. (2001), ‘Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays’, J. Clin. Microbiol. Vol. 39, pp. 4452–4445.
14. Coenye, T., Goris, J., Spilker, T., Vandamme, P. et al. (2002), ‘Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov’, J. Clin. Microbiol. Vol. 40, pp. 2062–2069.
15. Coenye, T., Goris, J., De Vos, P., Vandamme, P. et al. (2003), ‘Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov’, Int. J. Syst. Evol. Microbiol. Vol. 53, pp. 1075–1080.
16. Coenye, T., Spilker, T., Reik, R., Vandamme, P. et al. (2005), ‘Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis’, J. Clin. Microbiol. Vol. 43, pp. 3463–3466.
17. Harris, J.K., De Groote, M.A., Sagel, S.D., Zemanick, E.T. et al. (2007), ‘Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis’, Proc. Natl. Acad. Sci. USA Vol. 104, pp. 20529–20533.
18. Rogers, G.B., Hart, C.A., Mason, J.R., Hughes, M. et al. (2003), ‘Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling’, J. Clin. Microbiol. Vol. 41, pp. 3548–3558.
19. Bernhard, A.E., Colbert, D., McManus, J. and Field, K.G. (2005), ‘Microbial community dynamics based on 16S rRNA gene profiles in a Pacific Northwest estuary and its tributaries’, FEMS Microbiol. Ecol. Vol. 52, pp. 115–128.
20. Suzuki, M., Rappe, M.S. and Giovannoni, S.J. (1998), ‘Kinetic bias in estimates of coastal picoplankton community structure obtained by measurements of small-subunit rRNA gene PCR amplicon length het-erogeneity’, Appl. Environ. Micro. Vol. 64, pp. 4522–4529.
21. Mills, D.K., Fitzgerald, K., Litchfield, C.D. and Gillevet, P.M. (2003), ‘A comparison of DNA profiling techniques for monitoring nutrient impact on microbial community composition during bioremediation of petroleum-contaminated soils’, J. Microbiol. Methods Vol. 54, pp. 57–74.
22. Ritchie, N.J., Schutter, M.E., Dick, R.P. and Myrold, D.D. (2000), ‘Use of length heterogeneity PCR and fatty acid methyl ester profiles to characterize microbial communities in soil’, Appl. Environ. Microbiol. Vol. 66, pp. 1668–1675.
23. Coenye, T. and Vandamme, P. (2003), ‘Intragenomic heterogeneity between multiple 16S ribosomal RNA operons in sequenced bacterial genomes’, FEMS Microbiol. Lett. Vol. 228, pp. 45–49.
24. Case, R.J., Boucher, Y., Dahllof, I., Holmstrom, C. et al. (2007), ‘Use of 16S rRNA and rpoB genes as molecular markers for microbial ecology studies’, Appl. Environ. Microbiol. Vol. 73, pp. 278–288.
25. Moreno, L.I., Mills, D.K., Entry, J., Sautter, R.T. et al. (2006), ‘Microbial metagenome profiling using amplicon length heterogeneity-polymerase chain reaction proves more effective than elemental analysis in discrimi-nating soil specimens’, J. Forensic Sci. Vol. 51, pp. 1315–1322.
26. Miller, S.Z. (2003), ‘Molecular identification of microbes in the sputum of cystic fibrosis patients’, Thesis, Florida International University, Miami, FL.
27. Reischl, U., Pulz, M., Ehret, W. and Wolf, H. (1994), ‘PCR based detection of Mycobacterium in sputum samples using a simple and reliable DNA extraction protocol’, Biotechniques Vol. 17, pp. 844–845.
28. Klockgether, J., Wurdemann, D., Reva, O., Wiehlmann, L. et al. (2007), ‘Diversity of the abundant pKLC102/PAGI-2 family of genomic islands in Pseudomonas aeruginosa’, J. Bacteriol. Vol. 189, pp. 2443–2459.
29. Doud, M., Zeng, E., Schneper, L., Narasimhan, G. et al. (2009), ‘Approaches to analyse dynamic microbial communities such as those seen in cystic fibrosis lung’, Hum. Genomics Vol. 3, pp. 246–256.
30. Cocolin, L., Manzano, M., Cantoni, C. and Comi, G. (2001), ‘Denaturing gradient gel electrophoresis analysis of the 16S rRNA gene V1 region to monitor dynamic changes in the bacterial population during fermentation of Italian sausages’, Appl. Environ. Microbiol. Vol. 67, pp. 5113–5121.
31. Rees, G., Baldwin, D., Watson, G., Perryman, S. et al. (2004), ‘Ordination and significance testing of microbial community composition derived from terminal restriction fragment length polymorphisms: Application of multi-variate statistics’, Antonie Leeuwenhoek. Vol. 86, pp. 339–347.
32. Hartmann, M., Frey, B., Kolliker, R. and Widmer, F. (2005), ‘Semi-automated genetic analyses of soil microbial communities: Comparison of T-RFLP and RISA based on descriptive and discrimina-tive statistical approaches’, J. Microbiol. Methods Vol. 61, pp. 349–360.
33. Gonzalez, G., Doud, M., Mathee, K. and Narasimhan, G. (2009), ‘Computer-assisted bacterial identification using 16S rRNA sequence data’, 25th Southern Biomedical Engineering Conference: IFMBE Proceedings, Springer Berlin Heidelberg, Miami, FL, pp. 239–240.
34. Harrison, F. (2007), ‘Microbial ecology of the cystic fibrosis lung’, Microbiology Vol. 153, pp. 917–923.
35. Retsema, J., Girard, A., Schelkly, W., Manousos, M. et al. (1987), ‘Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms’, Antimicrob. Agents Chemother. Vol. 31, pp. 1939–1947.
36. Hughes, D.T. and Russell, N.J. (1982), ‘The use of trimethoprim-sulfamethoxazole in the treatment of chest infections’, Rev. Infect. Dis. Vol. 4, pp. 528–532.
37. Muder, R.R., Harris, A.P., Muller, S., Edmond, M. et al. (1996), ‘Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: A prospec-tive, multicenter study of 91 episodes’, Clin. Infect. Dis. Vol. 22, pp. 508–512.
38. Ramsey, B.W., Pepe, M.S., Quan, J.M., Otto, K.L. et al. (1999), ‘Intermittent administration of inhaled tobramycin in patients with cystic fibrosis’, N. Engl. J. Med. Vol. 340, pp. 23–30.
39. Beringer, P. (2001), ‘The clinical use of colistin in patients with cystic fibrosis’, Curr. Opin. Pulm. Med. Vol. 7, pp. 434–440.
40. Govan, J.R.W. and Nelson, J.W. (1993), ‘Microbiology of cystic fibrosis lung infections: Themes and issues’, J. R. Soc. Med. Vol. 86, pp. 11–18.
41. Margulies, M., Egholm, M., Altman, W.E., Attiya, S. et al. (2005), ‘Genome sequencing in microfabricated high-density picolitre reactors’, Nature Vol. 437, pp. 376–380.
42. Zeng, E., Mathee, K. and Narasimhan, G. (2007), ‘IEM: An algorithm for iterative enhancement of motifs using comparative genomics data’, Comput. Syst. Bioinformatics Conf. Vol. 6, pp. 227–235.
43. Wang, Y. and Qian, P.Y. (2009), ‘Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies’, PLoS ONE Vol. 4, p. e7401.
44. Fierer, N. and Jackson, R.B. (2006), ‘The diversity and biogeography of soil bacterial communities’, Proc. Natl. Acad. Sci. USAVol. 103, pp. 626–631.
45. Shade, A., Jones, S.E. and McMahon, K.D. (2008), ‘The influence of habitat heterogeneity on freshwater bacterial community composition and dynamics’, Environ. Microbiol. Vol. 10, pp. 1057–1067.
46. Boni, M.F. and Feldman, M.W. (2005), ‘Evolution of antibiotic resistance by human and bacterial niche construction’, Evolution Vol. 59, pp. 477–491.
47. Phillips, I., King, A. and Shannon, K. (2009), ‘Comparative in-vitro properties of the quinolones’, in: Andriole, V. (ed.), The Quinolones, Academic Press, San Diego, CA, pp. 99–137.
48. Scheld, M.W. (2003), ‘Maintaining fluorquinolone class efficacy: Review of influencing factors’, Emerg. Infect. Dis. Vol. 9, pp. 1–9.
49. Canton, R., Cobos, N., de Gracia, J., Baquero, F. et al. (2005), ‘Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients’, Clin. Microbiol. Infect. Vol. 11, pp. 690–703.
50. Beringer, P.M. and Appleman, M.D. (2000), ‘Unusual respiratory bacterial flora in cystic fibrosis: Microbiologic and clinical features’, Curr. Opin. Pulm. Med. Vol. 6, pp. 545–550.